Results from US pharma group show oral drug reduced body weight by 10.5% on average
US pharmaceutical group Eli Lilly has announced that the latest trial of its anti-obesity pill has met weight-loss targets, boosting its plans to seek approval for the drug as it fights for market dominance with rival Novo Nordisk.
Lilly said on Tues... [2255 chars]